Marktplatzangebote
Ein Angebot für € 33,00 €
  • Gebundenes Buch

Written by prolific specialists in the field,this second volume of the first comprehensive series on tuberculosis focuses on immunology and cell biology of the infection thereby perfectly complementing volumes on molecular biology an clinical as well as therapeutic aspects of TB.
Coinciding with the first TB therapies to enter clinical trials in 60 years, this is the most comprehensive account of the latest developments in clinical, therapeutic and basic research into the disease, presented by the most prolific researcher in the field.

Produktbeschreibung
Written by prolific specialists in the field,this second volume of the first comprehensive series on tuberculosis focuses on immunology and cell biology of the infection thereby perfectly complementing volumes on molecular biology an clinical as well as therapeutic aspects of TB.
Coinciding with the first TB therapies to enter clinical trials in 60 years, this is the most comprehensive account of the latest developments in clinical, therapeutic and basic research into the disease, presented by the most prolific researcher in the field.
Autorenporträt
Prof. Dr. Stefan H.E. Kaufmann is Founding Director of the Max Planck Institute for Infection Biology, Berlin. He has published more than 600 scientific articles and is member of numerous scientific societies and committees e.g. current President of the European Federation of Immunological Societies, and Chair of the Immunology division of the American Society of Microbiology. He has won numerous prestigious awards including the Scientific Prize of Smith Kline Beecham and the Pettenkofer Prize.

Warwick Britton is Professor of Medicine at the University of Sydney, Australia. He serves as Chairman of the State Committee for the Australian Society of Clinical Immunology and Allergy.